+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antipsychotic Drug"

Treatment Resistant Depression Therapeutics Market 2025-2029 - Product Thumbnail Image

Treatment Resistant Depression Therapeutics Market 2025-2029

  • Report
  • December 2024
  • 201 Pages
  • Global
From
Chronic Fatigue Syndrome Therapeutics Market 2024-2028 - Product Thumbnail Image

Chronic Fatigue Syndrome Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 145 Pages
  • Global
From
Bipolar Disorder Therapeutics Market 2024-2028 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 161 Pages
  • Global
From
Schizophrenia Drugs Market 2021-2025 - Product Thumbnail Image

Schizophrenia Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Antipsychotic Drugs Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Antipsychotic Drugs Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 142 Pages
  • Global
From
From
Psychotropic Drug Market in China - Product Thumbnail Image

Psychotropic Drug Market in China

  • Report
  • September 2025
  • 150 Pages
  • China
From
Loading Indicator

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth. The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more